Startup spotlight: Opus Genetics, with $19M, works to advance cures for blinding retinal diseases

RALEIGH - Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed

Related Keywords

Massachusetts ,United States ,University Of Pennsylvania ,Pennsylvania ,Philadelphia ,Junwei Sun ,Tjean Bennett ,Ben Yerxa ,Joe Schachle ,Williamf Chatlos ,Harvard Medical School ,Ocular Genomics Institute ,Perelman School Of Medicine ,Foundation Fighting Blindness ,Penn Center ,Manning Family Foundation ,Rd Fund ,Opus Genetics ,Bios Partners ,Emeritus Professor ,Perelman School ,Advanced Retinal Ocular Therapeutics ,Eric Pierce ,Massachusetts Eye ,Harvard Medical ,Chief Operating Officer Joe Schachle ,Chief Scientific Officer ,Ash Jayagopal ,Spark Therapeutics ,Mass Eye ,